Truvada + Atazanavir + Ritonavir
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
HIV Infections
Conditions
HIV Infections
Trial Timeline
Sep 1, 2005 → Jan 1, 2007
NCT ID
NCT00224445About Truvada + Atazanavir + Ritonavir
Truvada + Atazanavir + Ritonavir is a approved stage product being developed by Gilead Sciences for HIV Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT00224445. Target conditions include HIV Infections.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00224445 | Approved | Completed |
Competing Products
20 competing products in HIV Infections